SHERI L. TARR is the Founder and Chief Advisor of '68 Partners, a global consulting firm helping CBD, hemp, and cannabis brands, license applicants, and licensed operators, build sustainable businesses that have a transformative impact on consumers and patients. A former Big pharma sales and marketing executive who
commercialized FDA regulated products worldwide, Sheri has extensive real-world experience operating in highly regulated environments. After working for Fortune 500 pharmaceutical and medical device companies including Pfizer and Baxter, Sheri flipped the script and became an attorney who spent a distinguished career in the courtroom holding these companies accountable for deceptive marketing, defective manufacturing, and other regulatory violations.
More inspired by medical innovation than litigation, Sheri founded '68 Partners, a strategic consultancy dedicated to helping life sciences companies and cannabis brands build sustainable businesses that have a transformative impact on consumers, patients, and the economy. Sheri has been in the regulatory trenches for decades. She has witnessed first-hand the good, the bad, and the totally avoidable.
A former pharmaceutical executive and mass tort litigator, Sheri has a deep understanding of the complex business, organizational, and regulatory challenges faced by life sciences and cannabis industry stakeholders. She intimately knows the tension between profit and risk, and has seen the adverse consequences to companies and consumers alike when these priorities are misaligned. Using her business savvy and regulatory-legal know how, Sheri collaborates with clients to commercialize products, expand into new markets, and develop practical compliance and business strategies that strike a healthy balance between financial objectives and regulatory risk.
Over the course of her expansive healthcare, legal and consulting career, Sheri’s work has covered the spectrum of cannabis and life sciences, including CBD- and hemp-derived products from topicals to tinctures to edibles; medical devices; clinical laboratory testing and equipment; pharmaceuticals; cancer diagnostics and therapeutics; personalized medicine; and biomarker technologies. Since early 2018, Sheri Tarr has been deep in the cannabis industry, serving clients from early stage to established CBD, hemp, and cannabis brands; to prospective cannabis licensees; to retailers, cultivators, processors, and other licensed operators.
'68 Partners specializes in best compliance practices; Fractional Compliance support; seamless product commercialization; profitable business plans and brand strategies; FDA and promotional compliance; full-service cannabis license application preparation; and advocacy before critical audiences. Sheri’s regulatory compliance consulting and cannabis licensing experience spans multiple states including New Jersey, Illinois, New York, Georgia, Virginia, Pennsylvania, and beyond. A frequent speaker and educator, her thoughtful industry insights and guidance has been sought by legislators, regulators, law firms, and other industry stakeholders around the world.
A University of Michigan alumni and Chicago-Kent College of Law, Illinois Institute of Technology graduate, Sheri is a Forbes 50 Over 50 Women nominee, a self-taught photographer, and an advisory board member or Board director to life sciences companies and cannabis businesses.
